- Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
-
Yew WW, Koh WJ
- KMID: 2373768
- Korean J Intern Med.
- 2016 Jan;31(1):15-29.
- doi: 10.3904/kjim.2016.31.1.15
A worsening scenario of drug-resistant tuberculosis has increased the need for new treatment strategies to tackle this worldwide emergency. There is a pressing need to simplify and shorten the current... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Response and Adverse Reactions in Older Tuberculosis Patients with Immunocompromising Comorbidities
-
Kim SY, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Yang SC
- KMID: 1793172
- Yonsei Med J.
- 2013 Sep;54(5):1227-1233.
- doi: 10.3349/ymj.2013.54.5.1227
PURPOSE: The aim of this study was to elucidate the effects of immunocompromising comorbidities on treatment response and adverse reactions in older tuberculosis (TB) patients. MATERIALS AND METHODS: The medical records... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
-
Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ
- KMID: 1776587
- Korean J Intern Med.
- 2011 Jun;26(2):153-159.
- doi: 10.3904/kjim.2011.26.2.153
BACKGROUND/AIMS: To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB). METHODS: A retrospective analysis of 171 patients with MDR-TB receiving either levofloxacin or... -
- CITED
-
- Close
- SHARE
-
- Close
